Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension
Clinical trial NCT02531217 · COMPLETED
Trial details
- NCT number
- NCT02531217
- Sponsor
- aTyr Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-13
- Primary completion
- 2016-05-26
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.